CRISPR-Cas9 corrects hypertrophic cardiomyopathy gene mutation in human preimplantation embryos [PreClinical] – 2 Minute Medicine
New Straits Times Online |
CRISPR-Cas9 corrects hypertrophic cardiomyopathy gene mutation in human preimplantation embryos [PreClinical]
2 Minute Medicine This study was the first to use CRISPR-Cas9 to correct a harmful mutation without causing significant off-target effects. Although this genome editing technique is still far from clinical use and requires full discussion from a bioethics perspective … SAVVY: Are we looking at designer kids? New developments in human gene editing face an ethical and regulatory quagmire in the US Our View: Where should we draw the line on gene editing? |
